Division of Infectious Diseases, National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
J Clin Microbiol. 2012 May;50(5):1679-83. doi: 10.1128/JCM.06711-11. Epub 2012 Feb 29.
Although the presence of mecA is the genotypic determinant of methicillin-resistant Staphylococcus aureus (MRSA), certain MRSA strains, especially community-associated MRSA (C-MRSA), can display an oxacillin MIC in the Clinical and Laboratory Standards Institute susceptible breakpoint range (≤ 2 μg/ml). Among 91 and 180 isolates thought to be methicillin-susceptible S. aureus (MSSA) with oxacillin MICs of 2 and 1 μg/ml as determined by the Sensititre broth microdilution test initially, 52 (57.1%) and 6 (3.3%), respectively, were mecA positive. These mecA-positive low-oxacillin-MIC isolates belong to the dominant Taiwan C-MRSA clone (clonal complex [CC] 59), 56 of which carried SCCmec type V and were pvl positive, and 43 of which belonged to spa CC t437. All 271 isolates were retested by Sensititre, as well as by Vitek II and disk diffusion (DD). Based on the oxacillin results, the sensitivities of the Sensititre, Vitek II, and DD methods were 48.3% (28/58), 46.6% (27/58), and 89.6% (52/58), respectively. Although cefoxitin was better at detecting these isolates, 12.1, 10.4, and 5.2% of these isolates were still misidentified as MSSA by Sensititre, Vitek II, and DD, respectively. These results highlight the difficulty in the accurate identification of MRSA with borderline oxacillin MICs in the CC59:SCCmec V clone, which likely has contributed to its spread in the health care and community settings. Since this clone has now been detected in other countries, and since other C-MRSA lineages have also been found to have low-level β-lactam resistance, the findings of the present study may be relevant to other regions. Further studies are warranted to determine the extent and clinical impact of such misidentification.
虽然 mecA 的存在是耐甲氧西林金黄色葡萄球菌(MRSA)的基因决定因素,但某些 MRSA 菌株,特别是社区相关 MRSA(C-MRSA),在临床和实验室标准协会敏感折点范围内(≤2μg/ml)可表现出苯唑西林 MIC。在最初通过 Sensititre 肉汤微量稀释试验确定的 91 和 180 株被认为是苯唑西林敏感金黄色葡萄球菌(MSSA)且苯唑西林 MIC 分别为 2 和 1μg/ml 的分离株中,分别有 52(57.1%)和 6(3.3%)株 mecA 阳性。这些低苯唑西林 MIC 且 mecA 阳性的分离株属于优势台湾 C-MRSA 克隆(克隆复合体[CC]59),其中 56 株携带 SCCmec 类型 V 且 pvl 阳性,43 株属于 spa CC t437。所有 271 株分离株均通过 Sensititre 以及 Vitek II 和纸片扩散(DD)进行了重新检测。根据苯唑西林结果,Sensititre、Vitek II 和 DD 方法的敏感性分别为 48.3%(28/58)、46.6%(27/58)和 89.6%(52/58)。尽管头孢西丁更能检测到这些分离株,但 Sensititre、Vitek II 和 DD 分别仍有 12.1%、10.4%和 5.2%的分离株被错误鉴定为 MSSA。这些结果突出了在 CC59:SCCmec V 克隆中,准确鉴定边界苯唑西林 MIC 的 MRSA 存在困难,这可能促成了其在医疗保健和社区环境中的传播。由于该克隆现在已在其他国家检测到,并且其他 C-MRSA 谱系也被发现具有低水平的β-内酰胺耐药性,因此本研究的结果可能与其他地区相关。需要进一步的研究来确定这种错误鉴定的程度和临床影响。